Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2 Aberrations in NSCLC: So Close Yet So Far.
Sartori G, Belluomini L, Trovato R, Minari R, Caliò A, Ugel S, Milella M, Pilotto S. Sartori G, et al. Among authors: minari r. JCO Precis Oncol. 2020 Nov;4:1049-1051. doi: 10.1200/PO.20.00195. JCO Precis Oncol. 2020. PMID: 35050770 No abstract available.
Wide and Cystic Brain Metastases Reveal RET-Rearranged Non-Small-Cell Lung Cancers.
Facchinetti F, Bozzetti F, Gnetti L, Minari R, Crafa P, Rebuzzi SE, Ferrara R, Gruppioni E, Capizzi E, Giombelli E, Crisi G, Altimari A, Tiseo M. Facchinetti F, et al. Among authors: minari r. JCO Precis Oncol. 2019 Dec;3:1-7. doi: 10.1200/PO.19.00073. JCO Precis Oncol. 2019. PMID: 35100707 No abstract available.
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
Leonetti A, Minari R, Mazzaschi G, Gnetti L, La Monica S, Alfieri R, Campanini N, Verzè M, Olivani A, Ventura L, Tiseo M. Leonetti A, et al. Among authors: minari r. Front Oncol. 2021 Apr 26;11:642190. doi: 10.3389/fonc.2021.642190. eCollection 2021. Front Oncol. 2021. PMID: 33981604 Free PMC article.
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC.
Minari R, Bordi P, La Monica S, Squadrilli A, Leonetti A, Bottarelli L, Azzoni C, Lagrasta CAM, Gnetti L, Campanini N, Petronini PG, Alfieri R, Tiseo M. Minari R, et al. J Thorac Oncol. 2018 Jun;13(6):e89-e91. doi: 10.1016/j.jtho.2018.03.013. Epub 2018 Mar 27. J Thorac Oncol. 2018. PMID: 29596911 Free article. No abstract available.
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature.
Verzè M, Minari R, Gnetti L, Bordi P, Leonetti A, Cosenza A, Ferri L, Majori M, De Filippo M, Buti S, Gasparro D, Nizzoli R, Azzoni C, Bottarelli L, Squadrilli A, Mozzoni P, Tiseo M. Verzè M, et al. Among authors: minari r. Cancers (Basel). 2021 Oct 28;13(21):5403. doi: 10.3390/cancers13215403. Cancers (Basel). 2021. PMID: 34771566 Free PMC article.
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies.
Leonetti A, Verzè M, Minari R, Perrone F, Gnetti L, Bordi P, Pluchino M, Nizzoli R, Azzoni C, Bottarelli L, Lagrasta CAM, Mazzaschi G, Buti S, Gasparro D, Cosenza A, Ferri L, Majori M, De Filippo M, Ampollini L, La Monica S, Alfieri R, Silini EM, Tiseo M. Leonetti A, et al. Among authors: minari r. Br J Cancer. 2024 Jan;130(1):135-142. doi: 10.1038/s41416-023-02475-9. Epub 2023 Nov 8. Br J Cancer. 2024. PMID: 37938348
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC.
Bersanelli M, Minari R, Bordi P, Gnetti L, Bozzetti C, Squadrilli A, Lagrasta CA, Bottarelli L, Osipova G, Capelletto E, Mor M, Tiseo M. Bersanelli M, et al. Among authors: minari r. J Thorac Oncol. 2016 Oct;11(10):e121-3. doi: 10.1016/j.jtho.2016.05.019. Epub 2016 May 31. J Thorac Oncol. 2016. PMID: 27257132 Free article. No abstract available.
79 results